Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

Condition:   Pancreatic Cancer Metastatic Intervention:   Drug: C3 (Metformin, Simvastatin, and Digoxin) Sponsor:   State University of New York - Downstate Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials